CAS: 2229047-91-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Glofitamab REF: TM-T76685CAS: 2229047-91-8 | SDS-PAGE:98.2%;SEC-HPLC:98.0% | 450.00 €~2,144.00 € | Fri 04 Oct 24 |
 | Glofitamab REF: 3D-CLA1659CAS: 2229047-91-8 | - - - | To inquire | Tue 15 Oct 24 |
| Glofitamab REF: 3D-FG184074CAS: 2229047-91-8 | Min. 95% | 1,062.00 €~15,927.00 € | Fri 29 Nov 24 |
Glofitamab
CAS:2229047-91-8
Glofitamab (RO7082859), a bivalent antibody, targets CD20 on B-cells to aid T cell attack in …
Purity:
SDS-PAGE:98.2%;SEC-HPLC:98.0%
Color and Shape:
Solid
Ref: TM-T76685
| 1mg | 450.00 € | ||
| 5mg | 1,307.00 € | ||
| 10mg | 2,144.00 € |
Estimated delivery in United States, on Friday 4 Oct 2024
Ref: 3D-CLA1659
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 15 Oct 2024
GlofitamabÂ
CAS:2229047-91-8
Glofitamab is a bispecific monoclonal antibody that binds to both CD20 and CD3 surface antigens …
Purity:
Min. 95%
Ref: 3D-FG184074
| 1mg | 1,062.00 € | ||
| 5mg | 3,540.00 € | ||
| 10mg | 5,663.00 € | ||
| 25mg | 10,618.00 € | ||
| 50mg | 15,927.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
